Journal Mobile Options
Table of Contents
Vol. 26, No. 3, 2003
Issue release date: 2003
Kidney Blood Press Res 2003;26:176–184

Four Additional CLCN5 Exons Encode a Widely Expressed Novel Long CLC-5 Isoform but Fail to Explain Dent’s Phenotype in Patients without Mutations in the Short Variant

Ludwig M. · Waldegger S. · Nuutinen M. · Bökenkamp A. · Reissinger A. · Steckelbroeck S. · Utsch B.
aDepartment of Clinical Biochemistry, University of Bonn, Bonn, Germany; bDepartment of Paediatrics, University of Marburg, Marburg, Germany; cDepartment of Paediatrics and Adolescence, Oulu, Finland, and dChildren’s Hospital Medical Center, University of Bonn, Bonn, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Dent’s disease is caused by mutations in the CLCN5 gene coding for the chloride channel CLC-5. However, sequencing of CLCN5 exonic regions in some patients presenting with low-molecular-weight proteinuria and hypercalciuria – the hallmarks of Dent’s disease – failed to identify causative mutations. Aim: Given the observation that some species harbour a CLCN5 mRNA encoding an extended CLC-5 aminoterminus compared with the so far known human form, we worked on the presumption that an orthologous (longer) CLCN5 transcript is also present in humans and that our patients may have mutations herein. Methods: Extensive databank mining, reverse transcription polymerase chain reaction (RT-PCR) and automated sequencing were used in the search for novel CLCN5 transcripts. The human CLCN5 gene was investigated in 7 patients out of five families by direct automated sequencing of PCR-amplified DNA products. Results: Two new human CLCN5 transcripts expressed in kidney and various other tissues could be identified. These arise from a novel site of transcription initiation, alternative splicing and the use of four additional CLCN5 exons. If being translated, both these mRNAs would lead to an enlarged CLC-5 protein consisting of 816 amino acids by adding 70 aminoterminal residues to the so far known 746-amino-acid-long isoform. Sequence analysis of the henceforward 17 CLCN5 exons revealed no mutation in the patients with a phenotype resembling Dent’s disease. Conclusions: Despite the identification of further targets to explain Dent’s disease, the molecular defect in our patients remains to be elucidated. Hence, their phenotype may be explained by mutations that affect so far unknown regulating elements of the CLCN5 gene or another gene(s), probably encoding CLC-5 accessory protein(s).

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Dent CE, Friedman M: Hypercalciuric rickets associated with renal tubular damage. Arch Dis Child 1964;39:240–249.
  2. Wrong OM, Norden AG, Feest TG: Dent’s disease: A familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. Quart J Med 1994;87:473–493.
  3. Pook MA, Wrong O, Wooding C, Norden AGW, Feest TG, Thakker RV: Dent’s disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to Xp11.22. Hum Genet 1993;2:2129–2134.
  4. Fisher SE, Black GCM, Lloyd SE, Hatchwell E, Wrong O, Thakker RV, Craig IW: Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candidate for Dent’s disease (an X-linked hereditary nephrolithiasis). Hum Mol Genet 1994;3:2053–2059.
  5. Fisher SE, van Bakel I, Lloyd SE, Pearce SH, Thakker RV, Craig IW: Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis). Genomics 1995;29:598–606.

    External Resources

  6. Hayama A, Uchida S, Sasaki S, Marumo F: Isolation and characterization of the human CLC-5 chloride channel gene promoter. Gene 2000;261:355–364.
  7. Jentsch TJ, Friedrich T, Schriever A, Yamada H: The CLC chloride channel family. Pflügers Arch 1999;437:783–795.
  8. Günther W, Lüchow A, Gluzeaud F, Vandewalle A, Jentsch TJ: CLC-5, the chloride channel mutated in Dent’s disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci USA 1998,95:8075–8080.
  9. Devuyst O, Christie PT, Courtoy PJ, Beauwens R, Thakker RV: Intra-renal and subcellular distribution of the human chloride channel, CLC5, reveals a pathophysiological basis for Dent’s disease. Hum Mol Genet 1999;8:247–257.

    External Resources

  10. Piwon N, Günther W, Schwake M, Bosl MR, Jentsch TJ: CLC-5 Cl-channel disruption impairs endocytosis in a mouse model for Dent’s disease. Nature 2000;408:369–373.
  11. Lloyd SE, Pearce SHS, Fisher SE, et al: A common molecular basis for three inherited kidney stone diseases. Nature 1996;379:445–449.
  12. Lloyd SE, Pearce SHS, Günther W, Kawaguchi H, Igarashi T, Jentsch TJ, Thakker RV: Idiopathic low-molecular-weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children due to mutations of the renal chloride channel (CLCN5). J Clin Invest 1997;99:967–974.
  13. Oudet C, Martin-Coignard D, Pannetier S, Praud E, Champion G, Hanauer A: A second family with XLRH displays the mutation S244L in the CLCN5 gene. Hum Genet 1997;99:781–784.
  14. Lloyd SE, Günther W, Pearce SHS, et al: Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders. Hum Mol Genet 1997,6:1233–1239.
  15. Nakazato H, Hattori S, Furuse A, et al: Mutations in the CLCN5 gene in Japanese patients with familial idiopathic low-molecular-weight proteinuria. Kidney Int 1997;52:895–900.
  16. Akuta N, Lloyd SE, Igarashi T, et al: Mutations of CLCN5 in Japanese children with idiopathic low-molecular-weight proteinuria, hypercalciuria and nephrocalcinosis. Kidney Int 1997;52:911–916.
  17. Kelleher CL, Buckalew VM, Frederickson ED, Rhodes DJ, Conner DA, Seidman JG, Seidman CE: CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphatemic rickets. Kidney Int 1998;53:31–37.
  18. Morimoto T, Uchida S, Sakamoto H, et al: Mutations in CLCN5 chloride channel in Japanese patients with low-molecular-weight proteinuria. J Am Soc Nephrol 1998;9:811–818.
  19. Hoopes RR Jr, Hueber PA, Reid RJ Jr, et al: CLCN5 chloride-channel mutations in six new North American families with X-linked nephrolithiasis. Kidney Int 1998;54:698–705.
  20. Igarashi T, Günther W, Sekine T, et al: Functional characterization of renal chloride channel, CLCN5, mutations associated with Dent’sJapan disease. Kidney Int 1998;54:1850–1856.
  21. Nakazato H, Yoshimuta J, Karashima S, Matsumoto S, Endo F, Matsuda I, Hattori S: Chloride channel CLCN5 mutations in Japanese children with familial idiopathic low-molecular-weight proteinuria. Kidney Int 1999;55:63–70.
  22. Bosio M, Bianchi ML, Lloyd SE, Thakker RV: A familial syndrome due to Arg648Stop mutation in the X-linked renal chloride channel gene. Pediatr Nephrol 1999;13:278–283.
  23. Cox JPD, Yamamoto K, Christie PT, et al: Renal chloride channel, CLCN5, mutations in Dent’s disease. J Bone Miner Res 1999;14:1536–1542.
  24. Yamamoto K, Cox JPDT, Friedrich T, et al: Characterization of renal chloride channel (CLCN5) mutations in Dent’s disease. J Am Soc Nephrol 2000;11:1460–1468.
  25. Igarashi T, Inatomi J, Ohara T, Kuwahara T, Shimadzu M, Thakker RV: Clinical and genetic studies of CLCN5 mutations in Japanese families with Dent’s disease. Kidney Int 2000;58:520–527.

    External Resources

  26. Takemura T, Hino S, Ikeda M, Okada M, Igarashi T, Inatomi J, Yoshioka K: Identification of two novel mutations in the CLCN5 gene in Japanese patients with familial idiopathic low-molecular-weight proteinuria (Japanese Dent’s disease). Am J Kidney Dis 2001;37:138–143.
  27. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acid Res 1997;25:3389–3402.
  28. Huang X, Miller W: A time-efficient, linear space local similarity algorithm. Adv Appl Math 1991;12:337–357.
  29. Ludwig M, Beck A, Wickert L, Bolkenius U, Tittel B, Hinkel K, Bidlingmaier F: Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene. J Pediatr Endocrinol Metab 1998;11:657–664.
  30. Shapiro MB, Senapathy P: RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression. Nucleic Acids Res 1987;15:7155–7174.
  31. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 1986;321:209–213.
  32. Steinmeyer K, Schwappach B, Bens M, Vandewalle A, Jentsch TJ: Cloning and functional expression of rat CLC-5, a chloride channel related to kidney disease. J Biol Chem 1995;270:31172–31177.
  33. Jentsch TJ: Chloride channels are different. Nature 2002;415:276–277.
  34. Dutzler R, Campbell EB, Cadene M, Chait BT, MacKinnon R: X-ray structure of a CIC chloride channel at 3.0 Å reveals the molecular basis of anion selectivity. Nature 2002;415:287–294.
  35. Kyte J, Doolittle RF: A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982;157:105–132.
  36. Dong K, Xu J, Vanoye CG, Welch R, MacGregor GG, Giebisch G, Hebert SC: An amino acid triplet in the NH2 terminus of rat ROMK1 determines interaction with SUR2B. J Biol Chem 2001;276:44347–44353.
  37. Lin D, Sterling H, Lerea KM, Giebisch G, Wang WH: Protein kinase C (PKC)-induced phosphorylation of ROMK1 is essential for the surface expression of ROMK1 channels. J Biol Chem 2002;77:44278–44284.

    External Resources

  38. Falquet L, Pagni M, Bucher P, Hulo N, Sigrist CJ, Hofmann K, Bairoch A: The PROSITE database, its status in 2002. Nucleic Acids Res 2002;30:235–238.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50